GET DAILY SIGNALSAmerican Vanguard (AVD) Reports Weaker Q3 Results as Sales and Margins Slip
Key Takeaways
- American Vanguard reported third-quarter 2026 net sales of $108.4 million, down 9% from $119.3 million a year earlier and well below the $130 million consensus estimate.
- Adjusted earnings came in at a loss of $0.61 per share, sharply below the analyst consensus of a $0.01 loss, while adjusted EBITDA fell to roughly break-even.
- Gross margin contracted to 24.2% from 28.7% a year ago, driven by higher freight and raw material costs and lower fixed-cost leverage.
- International sales fell 17% in the quarter, which management attributed primarily to El Niño-related weather disruptions in Latin America.
- Liquidity improved, with cash rising to $84 million and net debt falling $40 million sequentially to about $183.8 million, supported by stronger customer prepayments.
- The company lowered its full-year 2026 outlook while continuing to advance a new product pipeline expected to add meaningful revenue in coming years.
Earnings Context and Why It Matters
American Vanguard's third-quarter report arrived at a pivotal moment for the specialty agricultural chemicals maker. The company has spent 2026 executing a business improvement plan focused on cost reduction, manufacturing consolidation, and working capital discipline, even as a broader agricultural downturn has kept distributors and retailers purchasing on an as-needed basis with lean inventories. Because the company carries significant leverage under its refinanced term loans, each quarter's cash generation and covenant headroom are closely watched. The Q3 results matter not only for what they reveal about margin trends and demand, but also for whether management's transformation efforts are translating into a stronger financial position ahead of the seasonally important fourth quarter. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
Reported Results
American Vanguard posted third-quarter 2026 net sales of $108.4 million, a 9% decline from $119.3 million in the prior-year period and below the roughly $130 million analysts had expected. The company reported a GAAP net loss of $17.7 million, or $0.61 per share, compared with a loss of $0.43 per share a year earlier. Adjusted earnings of negative $0.61 per share fell far short of the consensus estimate of a $0.01 loss.
By segment, U.S. crop sales declined 2% to about $42.3 million, U.S. specialty sales fell 2% to roughly $18.9 million, and international sales dropped 17% to approximately $47.2 million. Gross margin narrowed to 24.2% from 28.7%, with management citing freight costs that reduced margin by roughly 250 basis points, higher raw material costs, and lower fixed-cost leverage. Adjusted EBITDA declined to near break-even from $8.3 million in the year-ago quarter. Despite the earnings shortfall, the balance sheet showed progress: cash rose to $84 million and net debt fell sequentially to about $183.8 million, aided by stronger customer prepayments. From what I see, the liquidity improvement stands out as a positive note amid the pressure.
Market Reaction and Investor Sentiment
The market responded negatively to the results. AVD shares closed down roughly 15% to $0.82 following the November 9, 2026 release, reflecting the magnitude of the earnings miss and the lowering of full-year guidance. Investor sentiment had already been cautious heading into the quarter given the company's uneven execution track record in recent periods, and the sharp top- and bottom-line shortfall reinforced concerns about cost inflation and international demand. That said, the quarter also contained constructive signals, including improved liquidity, reduced net working capital, and a new product pipeline that management expects to contribute $15 million to $20 million in annualized revenue over the next 12 months.
Forward Outlook and Key Factors to Monitor
Looking ahead, investors should monitor several themes that will shape American Vanguard's trajectory. First is the company's updated full-year guidance. Management lowered its 2026 outlook following the weaker third quarter, so the fourth quarter—traditionally a period of significant customer prepayments—will be critical to validating whether the revised targets are achievable. Management indicated it expects roughly $45 million in fourth-quarter prepayment and early pay collections, a meaningful but smaller figure than the $55 million collected in the prior-year quarter.
Second, freight and raw material cost inflation remain central risks. The company has implemented price increases, but management noted those actions only mitigated earlier inflation rather than the continued cost escalation seen in the third quarter. A normalization in diesel and transportation costs would directly support gross margin recovery.
Third, the balance sheet warrants close attention. With a gross leverage ratio of 6.5 times against a covenant maximum of 6.7 times, covenant headroom is relatively narrow, and fourth-quarter cash generation will matter for reducing leverage heading into 2027.
Finally, the new product pipeline represents the company's primary growth lever. Management has pointed to acquisitions of four U.S. brands from Syngenta, a distribution agreement with Sipcam Agro, and the launch of Duro LQ, all intended to contribute incremental revenue. Progress on these launches, along with any improvement in the international agricultural environment, will be key signals for investors evaluating the company's recovery path. I'm watching this closely as the pipeline could provide meaningful support if execution stays on track.
Exploring Tickeron’s AI Tools for Deeper Analysis
In my own research process, I often turn to Tickeron’s AI-powered tools to cross-check patterns and signals across the broader market. The AI Screener stands out for its ability to filter stocks using technical patterns, fundamentals, and AI-driven signals, helping surface ideas beyond a single ticker. It has become a practical part of how I evaluate opportunities in sectors like agricultural chemicals.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Contributor
Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.
AVD's MACD Histogram just turned positive
The Moving Average Convergence Divergence (MACD) for AVD turned positive on October 28, 2026. Looking at past instances where AVD's MACD turned positive, the stock continued to rise in 33 of 47 cases over the following month. The odds of a continued upward trend are 70%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 5 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +6.54% 3-day Advance, the price is estimated to grow further. Considering data from situations where AVD advanced for three days, in 189 of 287 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.
AVD may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on November 04, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on AVD as a result. In 72 of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 80%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where AVD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 83%.
The Aroon Indicator for AVD entered a downward trend on November 09, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 10 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.157) is normal, around the industry mean (-0.492). P/E Ratio (-0.504) is within average values for comparable stocks, (8.794). Projected Growth (PEG Ratio) (0.390) is also within normal values, averaging (0.867). Dividend Yield (0.125) settles around the average of (0.126) among similar stocks. AVD's P/S Ratio (0.119) is slightly lower than the industry average of (1.476).
The Tickeron Price Growth Rating for this company is 93 (best 1 - 100 worst), indicating slightly worse than average price growth. AVD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 96 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AVD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 79, placing this stock worse than average.
Notable companies
Industry description
Market Cap
High and low price notable news
Volume
Fundamental Analysis Ratings
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Advertisement
General Information
a manufacturer of a diverse group of agricultural products
Industry ChemicalsAgricultural
Advertisement